1. ALLA AKTIER
  2. NYHETER
  3. SCANDINAVIAN REAL HEART

Scandinavian Real Heart

Nyheter Scandinavian Real Heart Nyheter alla bolag

Realheart Releases Annual Report for 2023

MARKN.

Today Realheart publishes the annual report for 2023.
 The annual report, including the auditor's report can be found at www.realheart.se and as attachment to this press release.
 
An English version/translation of the annual report will be released later.

For more information, please contact:
Ina Laura Perkins, CEO
Phone: +46 (0) 70 406 49 21 
E-mail: inalaura.perkins@realheart.se
Certified Adviser: Svensk Kapitalmarknadsgranskning AB, www.skmg.se

About Us
Scandinavian Real Heart is active in medical technology. The company conducts research and development in observations of the physiology of the heart. The development of the company's product, a complete artificial heart (TAH), takes place in collaboration with cardiac surgeons, researchers and engineers. The focus is on developing patented solutions that can imitate the blood circulation of the natural human heart. The solutions are intended for use by patients diagnosed with heart failure.

Attachments
ÅRSREDOVISNING Realheart 2023 SVE 240523 Inkl Rev Ber LU

Datum 2024-05-23, kl 10:15
Källa MFN
Bifogade filer
ÅRSREDOVISNING Realheart 2023 SVE 240523 Inkl Rev Ber LU
Affiliate
Alla Aktier tipsar: Har du redan ett konto på Avanza? Varför inte skapa ett på Nordnet också och jämföra funktioner, courtage mm. Det tar inte lång tid, du fixar det direkt här med BankID
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet